FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称NAVACAPRANT
异名/同义词1-(6-ETHYL-8-FLUORO-4-METHYL-3-(3-METHYL-1,2,4-OXADIAZOL-5- YL)QUINOLIN-2-YL)-N-(OXAN-4-YL)PIPERIDIN-4-AMINE
1-(6-ETHYL-8-FLUORO-4-METHYL-3-(3-METHYL-1,2,4-OXADIAZOL-5-YL)-2-QUINOLINYL)-N-(TETRAHYDRO-2H-PYRAN-4-YL)-4-PIPERIDINAMINE
4-PIPERIDINAMINE, 1-(6-ETHYL-8-FLUORO-4-METHYL-3-(3-METHYL-1,2,4-OXADIAZOL-5-YL)-2-QUINOLINYL)-N-(TETRAHYDRO-2H-PYRAN-4-YL)-
BTRX-140
BTRX335140
BTRX-335140
CYM53093
CYM-53093
NAVACAPRANT
NAVACAPRANT [INN]
NAVACAPRANT [USAN]
NMRA-140
NMRA335140
NMRA-335140
CAS登记号2244614-14-8
物质唯一标识(Unique Ingredient Identifier)XK5ILZ28KI
分子式C25H32FN5O2
国际化合物标识(International Chemical Identifier,InChI)CQOJHAJWCDJEAT-UHFFFAOYSA-N
SMILESC(C)c1cc(c2c(c1)c(c(c(N3CCC(CC3)NC4CCOCC4)n2)-c5onc(C)n5)C)F
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System